Dublin, Feb. 26, 2018 (GLOBE NEWSWIRE) -- The "Global Antidepressant Drugs Market - Analysis By Drugs Class, By Sales Channel, By Region, By Country: Opportunities and Forecasts (2018-2023)" report has been added to ResearchAndMarkets.com's offering.
The global antidepressants market is projected to display a robust growth represented by a CAGR of 3.12 % during 2018 - 2023.
The segment of Selective Serotonin Reuptake Inhibitors (SSRIs) drug class witnessed growth at a noteworthy rate over the past few years and in the forecast period on the back of rising awareness related metal disorders, rising healthcare expenditures along with rising disposable incomes.
Amongst the regions, North America accounts for the largest regional share in the global antidepressant drugs market in 2017. Key factors driving the robust growth rate of North America region include rising healthcare expenditure, addition of new drugs, rising disposable incomes, rising number of hospitals and clinics etc.
The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global antidepressants drug. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Antidepressants Market, By Value (Actual Period: 2013-2017, Forecast Period: 2018-2023)
- Antidepressant Drugs Market - Sizing and Growth
- Analysis By Drugs Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents
- Analysis By Sales Channels - Hospital & Clinics, Retail Pharmacies, Others
Country Analysis - U.S., Canada, Germany, United Kingdom, India, Japan China, Brazil, Saudi Arabia (Actual Period: 2013-2017, Forecast Period: 2018-2023)
- Antidepressant Drugs Market - Sizing and Growth
- Analysis By Drugs Class - Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitors, Selective -Norepinephrine Reuptake Inhibitors, Monoamine Oxidase Inhibitors, Benzodiazepines, Antipsychotics, Novel Agents
Other Report Highlights
- Market Dynamics - Drivers and Restraints
- Market Trends
- Porter Five Force Analysis
- Policy and Regulatory Landscape
- Company Analysis - Pfizer, GlaxoSmithKline, Allergan, Forest laboratories, Takeda, Novartis, Eli Lilly
Key Topics Covered:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. Antidepressant Drugs Market Outlook
5. Global Antidepressant Drugs Market: Growth and Forecast
6. Global Antidepressant Drugs Market: By Drugs Class
7. Global Antidepressant Drugs Market: By Sales Channels
8. Global Antidepressant Drugs Market: Pipeline Analysis
9. Global Antidepressant Drugs Market: Regional Analysis
10. Market Dynamics
11. Market Trends
12. Policy and Regulatory Landscape
13. Porter's Five Forces Analysis - Antidepressant Drugs Market
14. SWOT Analysis - Antidepressant Drugs Market
15. Company Profiles
- Pfizer
- GlaxoSmithKline
- Allergan
- Forest laboratories
- Takeda
- Novartis
- Eli Lilly
For more information about this report visit https://www.researchandmarkets.com/research/389htt/global?w=12